Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.49 USD 0.08%
Market Cap: 801.1m USD
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Cash Flow Statement

0
Operating Cash Flow
+0%
Growth Rates:
1 Year
+178%
3 Years
-80%
5 Years
-12%
7 Years
-
10 Years
-
0
Investing Cash Flow
+0%
Growth Rates:
1 Year
+74%
3 Years
+20%
5 Years
-647%
7 Years
-293%
10 Years
-405%
0
Financing Cash Flow
+0%
Growth Rates:
1 Year
+20%
3 Years
-90%
5 Years
-
7 Years
-53%
10 Years
-81%

Cash Flow Statement
Avid Bioservices Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Oct-2014 Jan-2015 Apr-2015 Jul-2015 Oct-2015 Jan-2016 Apr-2016 Jul-2016 Oct-2016 Jan-2017 Apr-2017 Jul-2017 Oct-2017 Jan-2018 Apr-2018 Jul-2018 Oct-2018 Jan-2019 Apr-2019 Jul-2019 Oct-2019 Jan-2020 Apr-2020 Jul-2020 Oct-2020 Jan-2021 Apr-2021 Jul-2021 Oct-2021 Jan-2022 Apr-2022 Jul-2022 Oct-2022 Jan-2023 Apr-2023 Jul-2023 Oct-2023 Jan-2024 Apr-2024 Jul-2024 Oct-2024
Operating Cash Flow
Net Income
(45)
(48)
(50)
(51)
(52)
(56)
(56)
(53)
(44)
(35)
(28)
(18)
(27)
(30)
(22)
(23)
(11)
(2)
(4)
(5)
(4)
(5)
(10)
(3)
0
4
11
13
14
14
128
123
118
116
1
(3)
(11)
(18)
(141)
(144)
(152)
Depreciation & Amortization
1
1
1
1
1
1
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
5
6
7
7
8
9
10
11
11
12
Change in Deffered Taxes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(115)
(114)
(117)
(115)
1
0
0
(3)
114
114
117
Stock-Based Compensation
7
7
7
6
5
5
5
5
4
4
3
3
2
2
2
1
1
1
2
2
2
2
3
3
3
3
4
4
5
6
7
8
9
9
11
11
11
11
10
10
0
Other Non-Cash Items
7
7
7
6
6
5
5
5
4
4
0
0
(0)
(1)
(8)
(8)
(13)
(13)
(4)
(4)
2
3
3
3
3
3
5
6
7
9
9
9
10
11
12
13
12
12
13
14
15
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
2
2
1
1
1
1
2
3
3
6
Change in Working Capital
(1)
1
7
3
7
13
10
6
8
(5)
(14)
(18)
(17)
(12)
1
6
1
(3)
(6)
(1)
5
8
11
3
4
6
12
5
2
0
(16)
(12)
(21)
(34)
(34)
(26)
(8)
11
13
12
13
Cash from Operating Activities
(39)
N/A
(40)
-3%
(36)
+10%
(41)
-13%
(38)
+5%
(36)
+5%
(40)
-9%
(40)
-2%
(30)
+26%
(33)
-12%
(39)
-18%
(33)
+15%
(42)
-25%
(40)
+5%
(26)
+34%
(21)
+18%
(21)
+3%
(15)
+27%
(12)
+23%
(7)
+43%
6
N/A
8
+41%
6
-31%
6
+3%
11
+75%
16
+55%
31
+90%
27
-15%
27
+1%
27
N/A
9
-65%
11
+20%
(3)
N/A
(15)
-409%
(13)
+14%
(8)
+37%
2
N/A
12
+562%
11
-12%
8
-31%
5
-30%
Investing Cash Flow
Capital Expenditures
(3)
(5)
(9)
(9)
(11)
(12)
(9)
(9)
(6)
(4)
(4)
(5)
(4)
(3)
(4)
(3)
(2)
(3)
(2)
(1)
(2)
(3)
(4)
(4)
(6)
(7)
(10)
(14)
(19)
(36)
(56)
(59)
(86)
(77)
(78)
(85)
(58)
(51)
(32)
(19)
(15)
Other Items
0
1
1
0
0
(0)
1
0
0
0
1
2
1
0
3
5
9
9
6
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
(3)
N/A
(4)
-49%
(8)
-91%
(8)
+2%
(11)
-32%
(12)
-11%
(9)
+28%
(8)
+4%
(6)
+32%
(4)
+35%
(3)
+18%
(3)
-1%
(4)
-23%
(3)
+27%
(1)
+71%
2
N/A
7
+171%
6
-7%
5
-26%
2
-63%
(2)
N/A
(3)
-62%
(4)
-18%
(4)
-12%
(6)
-36%
(7)
-12%
(10)
-52%
(14)
-38%
(19)
-38%
(36)
-92%
(56)
-57%
(59)
-5%
(86)
-45%
(77)
+10%
(78)
0%
(85)
-9%
(58)
+32%
(51)
+12%
(32)
+38%
(19)
+40%
(15)
+21%
Financing Cash Flow
Net Issuance of Common Stock
64
39
38
38
61
65
46
38
17
15
33
35
29
24
27
24
24
23
2
1
1
1
1
1
1
35
(4)
(4)
(3)
(36)
3
3
3
3
3
3
3
2
1
1
1
Net Issuance of Debt
(0)
(0)
(0)
(0)
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
4
(0)
(0)
(0)
121
126
126
126
(0)
(0)
(0)
(1)
(1)
(1)
7
7
19
18
11
Cash Paid for Dividends
(2)
(3)
(3)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
(3)
(2)
(1)
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
62
N/A
37
-41%
35
-4%
35
-1%
57
+64%
61
+7%
42
-31%
34
-19%
13
-63%
11
-13%
28
+155%
30
+7%
25
-18%
19
-22%
22
+15%
19
-14%
19
+0%
19
-1%
(3)
N/A
(4)
-27%
(4)
+3%
(3)
+13%
1
N/A
(3)
N/A
(3)
+8%
30
N/A
112
+270%
119
+6%
120
+1%
88
-26%
3
-96%
3
+0%
3
-19%
2
-9%
3
+22%
3
-6%
10
+257%
9
-8%
20
+125%
20
-2%
12
-40%
Change in Cash
Net Change in Cash
20
N/A
(8)
N/A
(9)
-20%
(14)
-50%
8
N/A
12
+62%
(7)
N/A
(15)
-125%
(23)
-55%
(26)
-13%
(14)
+46%
(6)
+55%
(21)
-226%
(23)
-11%
(5)
+80%
0
N/A
5
+2 061%
10
+98%
(10)
N/A
(9)
+14%
0
N/A
2
+361%
3
+47%
(2)
N/A
2
N/A
40
+2 252%
134
+232%
131
-2%
128
-3%
79
-38%
(44)
N/A
(45)
-2%
(86)
-94%
(90)
-4%
(88)
+3%
(90)
-3%
(46)
+49%
(30)
+36%
(1)
+97%
8
N/A
2
-76%
Free Cash Flow
Free Cash Flow
(42)
N/A
(45)
-7%
(45)
+0%
(49)
-10%
(49)
0%
(49)
+2%
(49)
-1%
(49)
+0%
(36)
+27%
(37)
-5%
(43)
-15%
(38)
+11%
(46)
-21%
(43)
+7%
(30)
+30%
(24)
+20%
(23)
+3%
(18)
+22%
(13)
+27%
(8)
+39%
4
N/A
5
+30%
2
-61%
2
-12%
5
+168%
10
+108%
21
+116%
13
-39%
8
-38%
(9)
N/A
(47)
-406%
(48)
-2%
(89)
-86%
(92)
-4%
(91)
+2%
(93)
-3%
(56)
+40%
(38)
+31%
(21)
+46%
(11)
+45%
(10)
+15%

See Also

Summary
CDMO intrinsic value, competitors valuation, and company profile.
DCF Valuation
CDMO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CDMO stock valuation using valuation multiples.
Wall Street Estimates
CDMO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CDMO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 246,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.